OLMEXA 25 MT
OLMEXA 25 MT is used for effective management of hypertension and cardiovascular risk. It contains Olmesartan Medoxomil 20 mg + Metoprolol Succinate 25 mg, offering dual action for better blood pressure control. Olmesartan relaxes blood vessels by blocking angiotensin II, while Metoprolol reduces heart rate and cardiac workload. This combination helps maintain stable blood pressure, supports heart health, and is commonly prescribed for long-term cardiovascular protection.
Related products
METOMED AM 25
METOMED AM 25 is a combination therapy used for effective management of hypertension and cardiovascular...
METOMED XL 50
METOMED XL 50 is used for the management of hypertension and various cardiac conditions. Each...
METOMED XL 25
METOMED XL 25 is used for the management of hypertension and heart-related conditions. Each extended-release...
TELLME TRIO CC
TELLME CC combines Telmisartan 40 mg + Cilnidipine 10 mg + Chlorthalidone 12.5 mg. This...
TELLME 80 CL
TELLME 80 CL contains Telmisartan 80 mg + Cilnidipine 10 mg, designed for patients needing...
